Wessén A, Widman M, Andersson J, Hartvig P, Valind S, Hetta J, Långström B
Department of Anaesthesiology, Hospital Pharmacy, Uppsala, Sweden.
Acta Anaesthesiol Scand. 1997 Oct;41(9):1204-12. doi: 10.1111/j.1399-6576.1997.tb04867.x.
The effects of eltanolone anaesthesia in humans on regional cerebral blood flow, regional cerebral metabolic rate of oxygen and oxygen extraction ratio were to be evaluated using positron emission tomography (PET).
Six healthy male volunteers were studied. Series of PET-measurements with 15O and H2(15)O were carried out in the awake state (baseline)(n = 6), during eltanolone anaesthesia (n = 5) and during early recovery (n = 5), when the subjects were oriented with respect to person, place and time. Eltanolone was given as a programmed infusion.
Cerebral blood flow (rCBF) was reduced in almost all cortex regions studied by 31 +/- 16% (mean +/- SD, P < 0.01). During recovery rCBF increased to 109 +/- 26% of pre-anaesthetic baseline levels (P < 0.01). Eltanolone in the doses administered lowered oxygen metabolism (rCMRO2) by 52 +/- 8% (P < 0.01) in cortex regions. During recovery rCMRO2 increased to 90 +/- 13% of baseline (P < 0.01). The oxygen extraction (OER) in cortical regions decreased by 32 +/- 23% (P < 0.01) during anaesthesia and returned to 82 +/- 10% of baseline (P < 0.01) during recovery. Less reduction in cortical blood flow during eltanolone anaesthesia was seen in the uncus (P < 0.01), though no differences in the depression of oxygen metabolism were seen. Oxygen extraction remained homogeneous throughout the brain.
Eltanolone anaesthesia was shown to reduce cerebral oxygen metabolism and cerebral blood flow in healthy volunteers. There were no signs of ischaemic effects.
使用正电子发射断层扫描(PET)评估依他诺龙麻醉对人体局部脑血流量、局部脑氧代谢率和氧摄取率的影响。
对6名健康男性志愿者进行研究。在清醒状态(基线,n = 6)、依他诺龙麻醉期间(n = 5)和早期恢复期间(n = 5),当受试者对人物、地点和时间有定向能力时,使用15O和H2(15)O进行系列PET测量。依他诺龙采用程序化输注给药。
几乎所有研究的皮质区域的脑血流量(rCBF)均降低了31±16%(平均值±标准差,P < 0.01)。恢复期间,rCBF增加至麻醉前基线水平的109±26%(P < 0.01)。所给药剂量的依他诺龙使皮质区域的氧代谢(rCMRO2)降低了52±8%(P < 0.01)。恢复期间,rCMRO2增加至基线的90±13%(P < 0.01)。麻醉期间,皮质区域的氧摄取(OER)降低了32±23%(P < 0.01),恢复期间恢复至基线的82±10%(P < 0.01)。在海马钩回,依他诺龙麻醉期间皮质血流量的降低较少(P < 0.01),尽管在氧代谢抑制方面未见差异。全脑氧摄取保持均匀。
依他诺龙麻醉可降低健康志愿者的脑氧代谢和脑血流量。没有缺血效应的迹象。